PDI Reducing Reliance On Top Pharma Clients
This article was originally published in The Pink Sheet Daily
Executive Summary
Contract sales organization’s top four clients – AstraZeneca, GSK, Novartis and Sanofi-Aventis – will represent 59% of 2005 revenue, versus 81% in 2004, PDI says. Contracts with three of the four companies have been renewed.
You may also be interested in...
Sanofi-Aventis Ends PDI Sales Contract
Big pharma is “reevaluating its commercial model,” PDI said in reaction to losing the $18 mil. to $20 mil. Sanofi contract.
Sanofi-Aventis Ends PDI Sales Contract
Big pharma is “reevaluating its commercial model,” PDI said in reaction to losing the $18 mil. to $20 mil. Sanofi contract.
AstraZeneca Likely To Reduce Its Contract Sales Force, PDI Says
The sales and marketing staffing firm currently contracts 800 reps to AstraZeneca.